Construction of ceRNA network based on RNA-seq for identifying prognostic lncRNA biomarkers in Perthes disease

Tianjiu Zhang1, Xiaolin Hu2, Song Yu1

  • 1Guizhou Children's Hospital, Department of Pediatric Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.

Frontiers in Genetics
|June 12, 2023
PubMed

Insights

This study reveals key molecular changes in a rabbit model of Perthes disease, identifying differentially expressed long non-coding RNAs, miRNAs, and mRNAs. These findings offer new insights into the pathogenesis of this childhood hip condition.

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Legg-Calvé-Perthes disease (Perthes disease) affects children aged 2-15 years, causing osteonecrosis of the femoral head and physical limitations.
  • The exact pathogenesis and molecular mechanisms of Perthes disease are not fully understood.

Purpose of the Study:

  • To investigate the expression patterns of long non-coding RNAs (lncRNAs), miRNAs, and mRNAs in a rabbit model of Perthes disease using transcriptome sequencing.
  • To identify potential molecular pathways and genetic players involved in the development of Perthes disease.

Main Methods:

  • Transcriptome sequencing (RNA-seq) was performed on a rabbit model of Perthes disease.
  • Weighted Gene Co-expression Network Analysis (WGCNA) was used to analyze differentially expressed mRNAs (DEmRNAs).
  • A competing endogenous RNA (ceRNA) network was constructed using differentially expressed lncRNAs, miRNAs, and DEmRNAs.

Main Results:

  • RNA-seq identified 77 differentially expressed lncRNAs, 239 miRNAs, and 1027 mRNAs.
  • WGCNA revealed downregulation of genes associated with angiogenesis and platelet activation.
  • A ceRNA network implicated specific lncRNAs (e.g., HIF3A), miRNAs (e.g., ocu-miR-574-5p), and mRNAs (e.g., ALOX12) in Perthes disease pathogenesis.

Conclusions:

  • The study provides novel insights into the molecular mechanisms and pathogenesis of Perthes disease.
  • The identified molecular players and pathways may serve as targets for future therapeutic strategies for Perthes disease.